Onconova Therapeutics prices upsized IPO at $15, above the range


Shutterstock photo

Onconova Therapeutics, a biotech focused on developing drug candidates for cancer and related diseases, raised $78 million by offering 5.2 million shares at $15, above the range of $12 to $14. The Newtown, PA-based company had originally planned to offer 4.6 million shares. Onconova Therapeutics, which now has a market cap of approximately $310 million, will list on the NASDAQ under the symbol ONTX. Citi and Leerink Swann acted as lead managers on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , IPOs

More from Renaissance Capital


Renaissance Capital

Renaissance Capital

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com